IRIS
FERAGALLI, Beatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.067
EU - Europa 2.482
AS - Asia 1.016
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
AF - Africa 4
Totale 6.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.044
IE - Irlanda 589
CN - Cina 540
IT - Italia 423
UA - Ucraina 407
SE - Svezia 368
TR - Turchia 322
GB - Regno Unito 184
DE - Germania 148
FR - Francia 123
FI - Finlandia 58
IN - India 56
ES - Italia 43
BE - Belgio 26
AT - Austria 22
HK - Hong Kong 17
PL - Polonia 17
CA - Canada 14
NL - Olanda 14
TH - Thailandia 14
RU - Federazione Russa 13
TW - Taiwan 12
ID - Indonesia 10
IR - Iran 10
AU - Australia 7
CZ - Repubblica Ceca 7
EU - Europa 7
JP - Giappone 7
BG - Bulgaria 6
CH - Svizzera 6
PT - Portogallo 6
CO - Colombia 5
SG - Singapore 5
VN - Vietnam 5
HR - Croazia 4
KR - Corea 4
MX - Messico 4
BR - Brasile 3
GR - Grecia 3
PK - Pakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
LU - Lussemburgo 2
MA - Marocco 2
ME - Montenegro 2
MM - Myanmar 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
EE - Estonia 1
GT - Guatemala 1
IL - Israele 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
SI - Slovenia 1
Totale 6.594
Salva come PNG Salva come JPEG
Città #
Chandler 665
Jacksonville 603
Dublin 573
Princeton 264
Nanjing 176
Izmir 172
Southend 135
Ashburn 124
Wilmington 122
Altamura 109
Cambridge 88
Beijing 79
Ann Arbor 76
Dearborn 67
Nanchang 58
Chieti 57
New York 47
Boardman 45
Kunming 35
Shenyang 32
Hebei 31
Tianjin 27
Menlo Park 26
Falls Church 24
Jiaxing 23
Woodbridge 22
Norwalk 19
Brussels 18
Santa Pola 18
Los Angeles 15
Washington 15
Seattle 14
Istanbul 13
Calpe 12
Hangzhou 12
Houston 11
Rome 11
Changsha 10
Taipei 10
Lanzhou 9
Toronto 9
Vienna 9
Waidhofen An Der Ybbs 9
Bangkok 8
Milan 8
Namur 8
Redwood City 8
Changchun 7
Hong Kong 7
Leawood 7
San Jose 7
Jinan 6
Kraków 6
London 6
Madrid 6
Santa Cruz 6
Shanghai 6
Zhengzhou 6
Dallas 5
Guangzhou 5
Guardiagrele 5
Mersin 5
Offenbach 5
San Mateo 5
San Michele al Tagliamento 5
Sofia 5
Amsterdam 4
Chicago 4
Darmstadt 4
Dong Ket 4
Edinburgh 4
Fairfield 4
Grevenbroich 4
Mexico 4
Mérignac 4
Ningbo 4
Pisa 4
Reston 4
Selcuklu 4
Siena 4
Tappahannock 4
Tehran 4
Warsaw 4
Zurich 4
Andover 3
Bogotá 3
Bologna 3
Brno 3
Chivasso 3
Cinisello Balsamo 3
Collecorvino 3
Cormeilles-en-Parisis 3
Frankfurt am Main 3
Helsinki 3
Jakarta 3
Kowloon 3
Paris 3
Pescara 3
Phitsanulok 3
Simi Valley 3
Totale 4.156
Salva come PNG Salva come JPEG
Nome #
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 137
Pulmonary nodule [Il nodulo polmonare] 116
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 104
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 103
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 103
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 97
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 94
Cone beam computed tomography for dental and maxillofacial imaging: technique improvement and low-dose protocols 93
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 90
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 89
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 85
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 84
Valutazione dell'area valvolare aortica (AVA): confronto fra risonanza cardiaca (RCM), ecocardiografiatranstoracia (ETT) e transesofagea (ETE) 83
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 82
Mononucleosis-related fatigue: supplementary management with Robuvit®. 81
Biomechanical aspects in late implant failures: Scanning electron microscopy analysis of four clinical cases 80
[Possibility of false negative results in the diagnosis of lung neoplasms with computerized tomography] 78
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 78
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 74
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 70
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 70
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 70
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 69
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 68
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 68
null 67
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 67
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 67
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 66
Non-small cell lung carcinoma. Early diagnosis: applicability of a screening 65
Robuvit®: improvement of fatigue in medical convalescence. 65
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 64
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 64
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit® 64
Malignant pleural disease 63
Pycnogenol® supplementation in minimal cognitive dysfunction 63
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 62
Ecografia toracica. Diagnosi e tecniche interventistiche 61
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 60
Malignant pleural disease 60
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 60
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 60
Small-Bowel Neoplasms: Role of MRI Enteroclysis 60
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 59
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 59
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 59
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 59
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 58
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations 57
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 56
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide 55
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 54
7T mMR in the assessment of acute arterial mesenteric ischemia in a rat model 53
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 53
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 53
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 53
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 53
Assessment of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging in comparison with transthoracic (TTE) and transesophageal echocardiography (TEE) 52
Anatomical features of cephalothoracopagus variations: CT and MRI. 52
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 52
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol® 52
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 52
Errors in imaging of traumatic injuries 51
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study 51
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 50
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 50
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 50
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study 50
Pycnogenol® supplementation improves cognitive function, attention and mental performance in students. 49
Prevention of vaginal dryness in perimenopausal women. Supplementation with Lady Prelox®. 49
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 49
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 48
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 48
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 47
Thoracic ultrasound in children: evidence and drawbacks 47
Hangover and fatigue: effects of Robuvit® supplementation. A pilot registry study. 47
Effects of different doses of Pycnogenol® on plasma oxidative stress: A pilot, supplement study 47
Pycnogenol® reduces the wheal and flare response to histamine in normal subjects 46
MR Imaging in Diagnosis of Pelvic Floor Descent: Supine versus Sitting Position 46
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 46
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry 46
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study 46
Pycnogenol® supplementation improves cognitive function, attention and mental performance in students.SourceIrvine3 Labs, Department of Biomedical Sciences Chieti - Pescara University, Pescara, Italy. 45
Pleural disease 45
Pycnogenol® prevents oxidative stress and side effects in patients with hypothyroidism during levothyroxine treatment 45
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. 44
Extrapleural and cardiophrenic lymph nodes: prevalence, clinical significance and diagnostic value 44
Improvement of common cold with Pycnogenol®: a Winter registry study. 44
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 44
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 44
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months 44
Radiographic evaluation of mediastinal lines as a diagnostic approach to occult or subtle mediastinal abnormalities. 43
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 43
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 43
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol® 43
HRCT in systemic sclerosis: correlation between respiratory functional indexes and extension of lung failure 42
MDCT venography in patients with suspected pulmonary embolism: diagnostic impact of pelvic vein evaluation in thromboembolic disease detection 42
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 42
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 42
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 41
Totale 6.088
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019253 0 0 0 0 0 0 0 0 0 0 21 232
2019/20201.365 409 87 38 17 138 54 129 94 49 111 192 47
2020/2021687 136 15 169 26 27 151 22 14 28 37 32 30
2021/2022683 25 19 12 106 78 38 20 50 37 22 77 199
2022/20231.935 187 280 95 202 168 372 121 158 213 26 74 39
2023/2024941 58 41 75 37 62 232 263 54 43 69 7 0
Totale 7.160